Reveal HealthTech builds bespoke AI solutions for healthcare and life‑sciences organizations, combining clinical domain expertise with engineering talent. Its flagship products include BioCanvas®, which enables multimodal AI use cases such as speeding clinical trial recruitment, and Prism AI®, for rapid development of intelligent agents to automate workflows. The company highlights a deployment for a $40B US medical device leader that improved patient adherence and produced a reusable blueprint for other clients. Reveal positions itself as a trusted, accountable AI partner and emphasizes a team drawn from top academic and healthcare technology institutions. In 2025 the company raised a $7.2M Series A to fund growth. Planned uses include expanding capabilities and solutions, strengthening its sales network, and extending its reach to more healthcare and life‑sciences leaders worldwide. Reveal HealthTech provides cross-functional technology services to healthcare companies, offering engineering, clinical, and strategic support. It partners with US-based healthcare organizations to maximize patient health outcomes by removing technology as a constraint to innovation and scale. The company will use the $4 million seed funding to further develop its service suite, establish a wider customer base, and expand talent acquisition, training, and development efforts. Reveal identified and partnered with top-quality senior technology talent in India and plans to access a pool of more than 150,000 engineers with US healthcare product experience—the largest specialized talent pool outside the US. The firm is focused on addressing talent challenges faced by healthcare organizations, including talent identification and selection, lack of healthcare domain expertise, and high turnover among software teams. The article frames the company's opportunity against rising US healthcare technology budgets, which are growing about 13% year-over-year and are estimated at $141 billion this year, with roughly $41 billion currently outsourced to technology services organizations.

Total raised

$11M

Funding rounds

2

Latest round

Series A

Latest activity

Sep 2025